108 related articles for article (PubMed ID: 9334586)
1. Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization.
Reeder JE; Morreale JF; O'Connell MJ; Stadler WM; Olopade OF; Messing EM; Wheeless LL
J Urol; 1997 Nov; 158(5):1717-21. PubMed ID: 9334586
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence.
Jung I; Reeder JE; Cox C; Siddiqui JF; O'Connell MJ; Collins L; Yang Z; Messing EM; Wheeless LL
J Urol; 1999 Dec; 162(6):1900-3. PubMed ID: 10569533
[TBL] [Abstract][Full Text] [Related]
3. DNA cytometry and chromosome 9 aberrations by fluorescence in situ hybridization of irrigation specimens from bladder cancer patients.
Reeder JE; O'Connell MJ; Yang Z; Morreale JF; Collins L; Frank IN; Messing EM; Cockett AT; Cox C; Robinson RD; Wheeless LL
Urology; 1998 May; 51(5A Suppl):58-61. PubMed ID: 9610559
[TBL] [Abstract][Full Text] [Related]
4. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
[TBL] [Abstract][Full Text] [Related]
6. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
[TBL] [Abstract][Full Text] [Related]
7. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
8. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
[TBL] [Abstract][Full Text] [Related]
9. Ethanol fixation of bladder irrigation specimens for flow cytometric analysis. A multiinstitutional study from the bladder cancer flow cytometry network.
Hermansen DK; Melamed MR; Coon JS; Weinstein RS; White RD; Deitch AD; Wheeless LL; Reeder JE; Wersto R; Koss LG
Cancer; 1989 May; 63(9):1780-3. PubMed ID: 2702585
[TBL] [Abstract][Full Text] [Related]
10. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience.
Klein FA; White FK
J Urol; 1988 Feb; 139(2):275-8. PubMed ID: 3339724
[TBL] [Abstract][Full Text] [Related]
12. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
[TBL] [Abstract][Full Text] [Related]
13. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.
Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
Eur Urol; 2000 Mar; 37(3):358-65. PubMed ID: 10720866
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
16. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of DNA measurement of bladder cancer from image cytometry and chromosome aberration in in situ hybridization].
Nemoto R; Nakamura I; Uchida K; Harada M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():153-7. PubMed ID: 7611780
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
19. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.
Gallucci M; Guadagni F; Marzano R; Leonardo C; Merola R; Sentinelli S; Ruggeri EM; Cantiani R; Sperduti I; Lopez Fde L; Cianciulli AM
J Clin Pathol; 2005 Apr; 58(4):367-71. PubMed ID: 15790699
[TBL] [Abstract][Full Text] [Related]
20. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
